share_log

醫渡科技：截至二零二四年一月三十一日止股份發行人的證券變動月報表

YIDU TECH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

香港交易所 ·  Feb 6 03:40
Summary by Moomoo AI
医渡科技有限公司於2024年2月6日向香港交易及結算所有限公司提交了截至2024年1月31日的證券變動月報表。報告顯示，公司的法定/註冊股本維持不變，為2,500,000,000股，每股面值0.00002美元，總額為50,000美元。在股份期權方面，根據首次公開發售後購股權計劃，有277,700股份期權已失效，而首次公開發售前購股權計劃2中有115,035股份期權被行使。本月內因行使期權所得資金總額為16,104.9港元。此外，經修訂首次公開發售後股份獎勵計劃下，本月內發行了78,725新股份。總計本月普通股增加了193,760股。公司確認，所有證券發行均已獲董事會批准，並符合香港聯合交易所有限公司證券上市規則的要求。
医渡科技有限公司於2024年2月6日向香港交易及結算所有限公司提交了截至2024年1月31日的證券變動月報表。報告顯示，公司的法定/註冊股本維持不變，為2,500,000,000股，每股面值0.00002美元，總額為50,000美元。在股份期權方面，根據首次公開發售後購股權計劃，有277,700股份期權已失效，而首次公開發售前購股權計劃2中有115,035股份期權被行使。本月內因行使期權所得資金總額為16,104.9港元。此外，經修訂首次公開發售後股份獎勵計劃下，本月內發行了78,725新股份。總計本月普通股增加了193,760股。公司確認，所有證券發行均已獲董事會批准，並符合香港聯合交易所有限公司證券上市規則的要求。
Medical Technology Limited filed with Hong Kong Trading and Settlement Limited on February 6, 2024 the Monthly Securities Change Report for the year ended January 31, 2024. The report showed that the company's regulated/registered share capital remained unchanged at 2,500,000,000 shares with a face value of $0.00002 per share for a total of $50,000. In terms of stock options, 277,700 share options have expired under the Initial Public Offering Possession Option Plan, and 115,035 share options were exercised under the Initial Public Offering Option Plan 2. The total amount of capital received from the exercise of options during the month was HK$16,104.9. In addition, 78,725 new shares were issued this month under the revised Initial Public Offering Share Award Scheme. In total, ordinary shares increased by 193,760 shares this month. The Company confirms that all securities issuance has been approved by the Board of Directors and complies with the requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Medical Technology Limited filed with Hong Kong Trading and Settlement Limited on February 6, 2024 the Monthly Securities Change Report for the year ended January 31, 2024. The report showed that the company's regulated/registered share capital remained unchanged at 2,500,000,000 shares with a face value of $0.00002 per share for a total of $50,000. In terms of stock options, 277,700 share options have expired under the Initial Public Offering Possession Option Plan, and 115,035 share options were exercised under the Initial Public Offering Option Plan 2. The total amount of capital received from the exercise of options during the month was HK$16,104.9. In addition, 78,725 new shares were issued this month under the revised Initial Public Offering Share Award Scheme. In total, ordinary shares increased by 193,760 shares this month. The Company confirms that all securities issuance has been approved by the Board of Directors and complies with the requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more